559 related articles for article (PubMed ID: 37829505)
1. The role of CD4
Xie L; Fang J; Yu J; Zhang W; He Z; Ye L; Wang H
MedComm (2020); 2023 Oct; 4(5):e390. PubMed ID: 37829505
[TBL] [Abstract][Full Text] [Related]
2. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
3. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells.
Knuschke T; Kollenda S; Wenzek C; Zelinskyy G; Steinbach P; Dittmer U; Buer J; Epple M; Westendorf AM
mBio; 2021 Feb; 12(1):. PubMed ID: 33531395
[TBL] [Abstract][Full Text] [Related]
4. CD4 T-cell immunotherapy for chronic viral infections and cancer.
Kamphorst AO; Ahmed R
Immunotherapy; 2013 Sep; 5(9):975-87. PubMed ID: 23998732
[TBL] [Abstract][Full Text] [Related]
5. CD4
Fu J; Yu A; Xiao X; Tang J; Zu X; Chen W; He B
Am J Cancer Res; 2020; 10(12):4234-4250. PubMed ID: 33414997
[TBL] [Abstract][Full Text] [Related]
6. CD4
Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
[TBL] [Abstract][Full Text] [Related]
7. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection.
Aubert RD; Kamphorst AO; Sarkar S; Vezys V; Ha SJ; Barber DL; Ye L; Sharpe AH; Freeman GJ; Ahmed R
Proc Natl Acad Sci U S A; 2011 Dec; 108(52):21182-7. PubMed ID: 22160724
[TBL] [Abstract][Full Text] [Related]
9. Harnessing Antitumor CD4
Ben Khelil M; Godet Y; Abdeljaoued S; Borg C; Adotévi O; Loyon R
Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008422
[TBL] [Abstract][Full Text] [Related]
10. Roles of CD4+ T cells as mediators of antitumor immunity.
Kravtsov DS; Erbe AK; Sondel PM; Rakhmilevich AL
Front Immunol; 2022; 13():972021. PubMed ID: 36159781
[TBL] [Abstract][Full Text] [Related]
11. Roles of regulatory T cells in cancer immunity.
Takeuchi Y; Nishikawa H
Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
[TBL] [Abstract][Full Text] [Related]
12. CD4
Wang B; Hu S; Fu X; Li L
Adv Biol (Weinh); 2023 Apr; 7(4):e2200169. PubMed ID: 36193961
[TBL] [Abstract][Full Text] [Related]
13. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
Seledtsov VI; Goncharov AG; Seledtsova GV
Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
[TBL] [Abstract][Full Text] [Related]
14. GITR intrinsically sustains early type 1 and late follicular helper CD4 T cell accumulation to control a chronic viral infection.
Clouthier DL; Zhou AC; Wortzman ME; Luft O; Levy GA; Watts TH
PLoS Pathog; 2015 Jan; 11(1):e1004517. PubMed ID: 25590581
[TBL] [Abstract][Full Text] [Related]
15. Broadening CD4
Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
[TBL] [Abstract][Full Text] [Related]
16. High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4
Hernandez R; LaPorte KM; Hsiung S; Santos Savio A; Malek TR
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34475132
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells.
Nesbeth YC; Martinez DG; Toraya S; Scarlett UK; Cubillos-Ruiz JR; Rutkowski MR; Conejo-Garcia JR
J Immunol; 2010 May; 184(10):5654-62. PubMed ID: 20400704
[TBL] [Abstract][Full Text] [Related]
18. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
Matloubian M; Concepcion RJ; Ahmed R
J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
[TBL] [Abstract][Full Text] [Related]
19. Neoantigen-specific stem cell memory-like CD4
Brightman SE; Becker A; Thota RR; Naradikian MS; Chihab L; Zavala KS; Ramamoorthy Premlal AL; Griswold RQ; Dolina JS; Cohen EEW; Miller AM; Peters B; Schoenberger SP
Nat Immunol; 2023 Aug; 24(8):1345-1357. PubMed ID: 37400675
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity of CD8(+) T cells independently of CD4(+) T cell help.
McCoy KD; Hermans IF; Fraser JH; Le Gros G; Ronchese F
J Exp Med; 1999 Apr; 189(7):1157-62. PubMed ID: 10190907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
